Principal Investigator
David Kerman
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20240037
Clinical Trial Summary
A PHASE II, MULTICENTER INDUCTION STUDY WITH AN ACTIVE TREATMENT EXTENSION TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF VIXARELIMAB IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Niurka Colina
Phone Number
+1 (305) 2436405
Email
nxc610@miami.edu